Drugs / PEV2A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00445419 | Dec 2006 → Jun 2008 | chronic hepatitis C virus infection | Pevion Biotech Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEV2A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00445419 ↗ |
| Modality | Vaccine | “HCV vaccine candidate” NCT00445419 ↗ |